Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 675786, 9 pages
http://dx.doi.org/10.1155/2014/675786
Research Article

Monocolonization of Germ-Free Mice with Bacteroides fragilis Protects against Dextran Sulfate Sodium-Induced Acute Colitis

1Graduate Institute of Sports Science, National Taiwan Sport University, Taoyuan 333, Taiwan
2Department of Molecular Biology and Human Genetics, Tzu Chi University, Hualien 970, Taiwan
3Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
4National Applied Research Laboratories, National Laboratory Animal Center, Taipei 115, Taiwan
5Department of Microbiology, National Taiwan University College of Medicine, Taipei 115, Taiwan

Received 13 March 2014; Accepted 27 April 2014; Published 29 May 2014

Academic Editor: Sang Hoon Rhee

Copyright © 2014 Chien-Chao Chiu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. K. Podolsky, “Medical progress: inflammatory bowel disease,” The New England Journal of Medicine, vol. 325, no. 14, pp. 1008–1016, 1991. View at Publisher · View at Google Scholar · View at Scopus
  2. T. Ohkusa, “Production of experimental ulcerative colitis in hamsters by dextran sulfate sodium and change in intestinal microflora,” Nihon Shokakibyo Gakkai Zasshi, vol. 82, no. 5, pp. 1327–1336, 1985. View at Google Scholar · View at Scopus
  3. G. Monteleone, F. Pallone, and T. T. MacDonald, “Emerging immunological targets in inflammatory bowel disease,” Current Opinion in Pharmacology, vol. 11, no. 6, pp. 640–645, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. R. Mahida, K. Wu, and D. P. Jewell, “Enhanced production of interleukin 1-β by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease,” Gut, vol. 30, no. 6, pp. 835–838, 1989. View at Google Scholar · View at Scopus
  5. R. Atreya, J. Mudter, S. Finotto et al., “Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo,” Nature Medicine, vol. 6, no. 5, pp. 583–588, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Komatsu, D. Kobayashi, K. Saito et al., “Tumor necrosis factor-α in serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR,” Clinical Chemistry, vol. 47, no. 7, pp. 1297–1301, 2001. View at Google Scholar · View at Scopus
  7. S. Fujino, A. Andoh, S. Bamba et al., “Increased expression of interleukin 17 in inflammatory bowel disease,” Gut, vol. 52, no. 1, pp. 65–70, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. S. K. Mazmanian, J. L. Round, and D. L. Kasper, “A microbial symbiosis factor prevents intestinal inflammatory disease,” Nature, vol. 453, no. 7195, pp. 620–625, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Ogawa, A. Andoh, Y. Araki, T. Bamba, and Y. Fujiyama, “Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice,” Clinical Immunology, vol. 110, no. 1, pp. 55–62, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. W. O'Connor Jr., M. Kamanaka, C. J. Booth et al., “A protective function for interleukin 17A in T cell-mediated intestinal inflammation,” Nature Immunology, vol. 10, no. 6, pp. 603–609, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. J. Hansen, Y. Huang, D. A. Peterson et al., “The colitis-associated transcriptional profile of commensal Bacteroides thetaiotaomicron enhances adaptive immune responses to a bacterial antigen,” PLoS ONE, vol. 7, no. 8, Article ID e42645, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Hakansson, N. Tormo-Badia, A. Baridi et al., “Immunological alteration and changes of gut microbiota after dextran sulfate sodium (DSS) administration in mice,” Clinical and Experimental Medicine, 2014. View at Publisher · View at Google Scholar
  13. S. K. Mazmanian, C. H. Liu, A. O. Tzianabos, and D. L. Kasper, “An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system,” Cell, vol. 122, no. 1, pp. 107–118, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. J. L. Round and S. K. Mazmanian, “Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 27, pp. 12204–12209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Hudcovic, H. Kozáková, J. Kolínská, R. Štěpánková, T. Hrnčíř, and H. Tlaskalová-Hogenová, “Monocolonization with Bacteroides ovatus protects immunodeficient SCID mice from mortality in chronic intestinal inflammation caused by long-lasting dextran sodium sulfate treatment,” Physiological Research, vol. 58, no. 1, pp. 101–110, 2009. View at Google Scholar · View at Scopus
  16. J. M. Uronis, M. Mühlbauer, H. H. Herfarth, T. C. Rubinas, G. S. Jones, and C. Jobin, “Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility,” PLoS ONE, vol. 4, no. 6, Article ID e6026, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Kitajima, M. Morimoto, E. Sagara, C. Shimizu, and Y. Ikeda, “Dextran sodium sulfate-induced colitis in germ-free IQI/Jic mice,” Experimental Animals, vol. 50, no. 5, pp. 387–395, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. M. S. Geier, R. N. Butler, P. M. Giffard, and G. S. Howarth, “Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats,” International Journal of Food Microbiology, vol. 114, no. 3, pp. 267–274, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Osman, D. Adawi, S. Ahrné, B. Jeppsson, and G. Molin, “Probiotics and blueberry attenuate the severity of dextran sulfate sodium (DSS)-induced colitis,” Digestive Diseases and Sciences, vol. 53, no. 9, pp. 2464–2473, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Kokešová, L. Frolová, M. Kverka et al., “Oral administration of probiotic bacteria (E. coli Nissle, E. coli O83, Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice,” Folia Microbiologica, vol. 51, no. 5, pp. 478–484, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Heilpern and A. Szilagyi, “Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, prebiotics and synbiotics,” Reviews on Recent Clinical Trials, vol. 3, no. 3, pp. 167–184, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Teran-Ventura, M. Aguilera, P. Vergara, and V. Martínez, “Specific changes of gut commensal microbiota and TLRs during indomethacin-induced acute intestinal inflammation in rats,” Jounnal of Crohns and Colitis, 2014. View at Publisher · View at Google Scholar
  23. M. Mähler, I. J. Bristol, E. H. Leiter et al., “Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis,” The American Journal of Physiology, vol. 274, no. 3, part 1, pp. G544–G551, 1998. View at Google Scholar · View at Scopus
  24. A. C. Bylund-Fellenius, E. Landstrom, L. G. Axelsson, and T. Midtvedt, “Experimental colitis induced by dextran sulphate in normal and germfree mice,” Microbial Ecology in Health and Disease, vol. 7, no. 4, pp. 207–215, 1994. View at Google Scholar · View at Scopus
  25. C. Dai, C.-Q. Zheng, F.-J. Meng, Z. Zhou, L.-X. Sang, and M. Jiang, “VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-κB pathway in rat model of DSS-induced colitis,” Molecular and Cellular Biochemistry, vol. 374, no. 1-2, pp. 1–11, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. J. J. Hansen, L. Holt, and R. B. Sartor, “Gene expression patterns in experimental colitis in IL-10-deficient mice,” Inflammatory Bowel Diseases, vol. 15, no. 6, pp. 890–899, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. R. K. Cross and K. T. Wilson, “Nitric oxide in inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 9, no. 3, pp. 179–189, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Hokari, S. Kato, K. Matsuzaki et al., “Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis,” Free Radical Biology and Medicine, vol. 31, no. 2, pp. 153–163, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. D. N. Seril, J. Liao, and G.-Y. Yang, “Colorectal carcinoma development in inducible nitric oxide synthase-deficient mice with dextran sulfate sodium-induced ulcerative colitis,” Molecular Carcinogenesis, vol. 46, no. 5, pp. 341–353, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. S. R. Jadhav, U. K. Shandilya, and V. K. Kansal, “Exploring the ameliorative potential of probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum on dextran sodium sulphate induced colitis in mice,” Journal of Dairy Research, vol. 80, no. 1, pp. 21–27, 2013. View at Publisher · View at Google Scholar · View at Scopus